The majority of T lymphocytes are polyclonal during the chronic phase of chronic myelogenous leukemia

Ann Hematol. 1996 Feb;72(2):61-5. doi: 10.1007/BF00641309.

Abstract

To clarify the extent of cell lineage involvement in chronic myelogenous leukemia (CML), we investigated the bcr gene rearrangement and clonality using the X-chromosome-linked restriction fragment length polymorphism (RFLP) methylation method in T lymphocytes and granulocytes. We examined the granulocyte and T-cell fractions from the peripheral blood of seven female patients with CML during the chronic phase; patients were heterozygous for RFLPs at the phosphoglycerate kinase (PGK) or the hypoxanthine phosphoribosyltransferase (HPRT) gene. RFLP-methylation analysis of granulocytes demonstrated a monoclonal pattern in six of the seven patients and a rearranged bcr gene in all seven patients. In contrast, T lymphocytes exhibited a polyclonal pattern in six cases; in one case, a faint band was observed following methyl-sensitive enzyme cleavage. The bcr gene analysis in T lymphocytes showed the germline in every case. Our results indicate that the majority of T lymphocytes are polyclonal during the chronic phase of CML and confirm previous reports based on glucose-6-phosphate dehydrogenase, cytogenetic, and bcr rearrangement analyses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / genetics
  • Clone Cells / pathology*
  • Female
  • Fusion Proteins, bcr-abl / analysis
  • Fusion Proteins, bcr-abl / genetics
  • Heterozygote
  • Humans
  • Hypoxanthine Phosphoribosyltransferase / analysis
  • Hypoxanthine Phosphoribosyltransferase / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Middle Aged
  • Neoplasm Proteins / analysis
  • Neoplasm Proteins / genetics
  • Phosphoglycerate Kinase / analysis
  • Phosphoglycerate Kinase / genetics
  • Polymorphism, Restriction Fragment Length
  • T-Lymphocyte Subsets / pathology*

Substances

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Hypoxanthine Phosphoribosyltransferase
  • Fusion Proteins, bcr-abl
  • Phosphoglycerate Kinase